Mechanisms Regulating Skin Pigmentation: The Rise and Fall of Complexion Coloration
Open accessThe DOI matches its Crossref record; 121 of the 127 references it cites were found in a registry or an index.
Abstract
Skin pigmentary abnormalities are seen as aesthetically unfavorable and have led to the development of cosmetic and therapeutic treatment modalities of varying efficacy. Hence, several putative depigmenting agents aimed at modulating skin pigmentation are currently being researched or sold in commercially available products. In this review we will discuss the regulation of processes that control skin complexion coloration. This includes direct inhibition of tyrosinase and related melanogenic enzymes, regulation of melanocyte homeostasis, alteration of constitutive and facultative pigmentation and down-regulation of melanosome transfer to the keratinocytes. These various processes, in the complex mechanism of skin pigmentation, can be regulated individually or concomitantly to alter complexion coloration and thus ameliorate skin complexion diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Scheme 1. Process of melanogenesis within epidermal melanosomes. Tyrosinase, the rate limiting enzyme of melanogenesis, catalyzes the hydroxylation of l-tyrosine to DOPA and the oxidation of DOPA to DOPAquinone. If cysteine or glutathione is present, it reacts with DOPAquinone to produce cysteinylDOPA and the benzothiazine derivatives of pheomelanin. As cysteine is diminished, DOPAquinone cyclizes into DOPAchrome. TYRP-2 catalyzes the tautomerization of DOPAchrome to 5,6-dihydroxyindole-2-carboxylic acid (DHICA), which is later oxidized to DHICA-melanin subunits. The oxidation of DHICA to eumelanin is thought to be catalyzed by TYRP-1. In the absence of TYRP-2 the carboxylic acid moiety of DOPAchrome is spontaneously lost to form 5,6-dihydroxyindole (DHI). DHICA in conjunction with DHI comprise subunits of eumelanin [11,12].](https://figures.cochat.ai/paper-figures/004566509c8849459759144469dd6b90/mechanisms-regulating-skin-pigmentation-the-rise-and-fall-of-complexion-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biological effects of resveratrol
Frémont, L. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00410-5 · Cited by 1,663 · cited 1×
“Commonly studied hydroxystilbene products include resveratrol (3,4’,5 trihydroxystilbene), its isomer oxyresveratrol and methoxylated or glycosylated analogs piceid-glucoside, rhapontigenin and rhaponticin [20,73].”
BackgroundMITF: master regulator of melanocyte development and melanoma oncogene
Levy, C., Khaled, M., & Fisher, D. E. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.008 · Cited by 1,169
Kim, Y.-J., & Uyama, H. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5054-y · Cited by 1,062 · cited 4×
“α-keto group show potent tyrosinase inhibition due to the similarity between the dihydroxyphenyl group of DOPA and the α-keto containing flavonoids [63].”
BackgroundInfluentialChemical and Instrumental Approaches to Treat Hyperpigmentation
Briganti, S., Camera, E., & Picardo, M. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00029.x · Cited by 837 · cited 10×
“skin pigmentation, freckles, nevi and senile lentigenes [6,10,65].”
BackgroundInfluentialMelanocytes and the Microphthalmia Transcription Factor Network
Steingrímsson, E., Copeland, N. G., & Jenkins, N. A. (2004) · Annual Review of Genetics · doi:10.1146/annurev.genet.38.072902.092717 · Cited by 771 · cited 1×
“syndrome type IIA [16,17].”
McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y.-L., Ramaswamy, S., Avery, W., Ding, H.-F., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00762-6 · Cited by 760 · cited 1×
“Pertaining to survival, MITF regulates the anti-apoptotic molecule Bcl-2 as well as additional survival genes [33,34].”
BackgroundHypopigmenting agents: an updated review on biological, chemical and clinical aspects
Solano, F., Briganti, S., Picardo, M., & Ghanem, G. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00334.x · Cited by 696 · cited 10×
“2000/6/EC) and formulations have been withdrawn from cosmetics and are available only through prescription [10,20,50].”
BackgroundInfluentialMAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes
Hemesath, T. J., Price, E. R., Takemoto, C., Badalian, T., & Fisher, D. E. (1998) · Nature · doi:10.1038/34681 · Cited by 630 · cited 1×
“ERK activation, in those cases, is thought to result in phosphorylation of MITF and its subsequent ubiquitination and degradation [25,28-30].”
BackgroundWu, M., Hemesath, T. J., Takemoto, C. M., Horstmann, M. A., Wells, A. G., Price, E. R., Fisher, D. Z., & Fisher, D. E. (2000) · Genes & Development · doi:10.1101/gad.14.3.301 · Cited by 527 · cited 1×
“ERK activation, in those cases, is thought to result in phosphorylation of MITF and its subsequent ubiquitination and degradation [25,28-30].”
BackgroundA Chemist's View of Melanogenesis
Ito, S. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00037.x · Cited by 508 · cited 1×
“DHICA in conjunction with DHI comprise subunits of eumelanin [11,12].”
BackgroundThe Regulation of Skin Pigmentation
Yamaguchi, Y., Brenner, M., & Hearing, V. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700026200 · Cited by 492 · cited 1×
“DHICA in conjunction with DHI comprise subunits of eumelanin [11,12].”
BackgroundThe effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer
Hakozaki, T., Minwalla, L., Zhuang, J., Chhoa, M., Matsubara, A., Miyamoto, K., Greatens, A., Hillebrand, G. G., Bissett, D. L., & Boissy, R. E. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04834.x · Cited by 488 · cited 5×
“Additionally, niacinamide is believed to influence cutaneous pigmentation by down-regulating transfer of melanosomes from the melanocytes to the keratinocytes [20,57,92].”
BackgroundInfluentialSelf-citationParvez, S., Kang, M., Chung, H., & Bae, H. (2007) · Phytotherapy Research · doi:10.1002/ptr.2184 · Cited by 409
Survey and mechanism of skin depigmenting and lightening agents
Parvez, S., Kang, M., Chung, H., Cho, C., Hong, M., Shin, M., & Bae, H. (2006) · Phytotherapy Research · doi:10.1002/ptr.1954 · Cited by 403
Draelos, Z. D. (2007) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2007.00144.x · Cited by 390 · cited 7×
“fungal metabolite obtained from species of Acetobacter, Aspergillus and Penicillium [48,49].”
BackgroundInfluentialThe Bowman‐Birk inhibitor. Trypsin‐ and chymotrypsin‐inhibitor from soybeans
BIRK, Y. (1985) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1985.tb02155.x · Cited by 390 · cited 1×
“STI inhibits trypsin proteolysis by forming a stable stoichiometric complex and BBI inhibits trypsin and chymotrypsin at separate reactive sites [106,108].”
BackgroundHuman pigmentation genes: identification, structure and consequences of polymorphic variation
Sturm, R. A., Teasdale, R. D., & Box, N. F. (2001) · Gene · doi:10.1016/s0378-1119(01)00694-1 · Cited by 390 · cited 1×
“Specifically, the enzyme catalyzes the hydroxylation of the monophenol L-tyrosine to the o-diphenol 3,4-dihydroxyphenylalanine (DOPA) and the oxidation of DOPA to the o-quinone DOPAquinone (Scheme 1) [8,9].”
BackgroundWidlund, H. R., & Fisher, D. E. (2003) · Oncogene · doi:10.1038/sj.onc.1206443 · Cited by 371 · cited 1×
“In addition to the process of melanization, MITF also regulates melanocyte differentiation, development, and survival [32].”
BackgroundYasumoto, K., Yokoyama, K., Shibata, K., Tomita, Y., & Shibahara, S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8058 · Cited by 368 · cited 1×
“[7,10,13,15,18,19].”
Approaches to Identify Inhibitors of Melanin Biosynthesis via the Quality Control of Tyrosinase
Ando, H., Kondoh, H., Ichihashi, M., & Hearing, V. J. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700683 · Cited by 365 · cited 1×
“Tyrosinase, the rate limiting enzyme of the melanogenic pathway, is a copper containing glycoprotein of approximately 60-70 kDa and a common target for therapeutic agents intended to alleviate cutaneous hyperpigmentation [6,7].”
BackgroundOxyresveratrol and Hydroxystilbene Compounds
Kim, Y. M., Yun, J., Lee, C.-K., Lee, H., Min, K. R., & Kim, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200678200 · Cited by 323
Melasma: Etiologic and Therapeutic Considerations
Grimes, P. E. (1995) · Archives of Dermatology · doi:10.1001/archderm.1995.01690240119022 · Cited by 322 · cited 3×
“20% azelaic acid seems to be well tolerated in treated patients with no systemic side effects, but some local cutaneous irritation, a burning sensation, mild erythema, scaling and pruritus that subsided 2 to 4 weeks post treatment [65,67].”
BackgroundResultZhu, W., & Gao, J. (2008) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/jidsymp.2008.8 · Cited by 277 · cited 3×
“The two adhere to different mechanisms of action where aloesin exhibits noncompetitive inhibition while arbutin inhibits competitively [49,64,69-71].”
BackgroundMelanosome transfer to and translocation in the keratinocyte
Boissy, R. E. (2003) · Experimental Dermatology · doi:10.1034/j.1600-0625.12.s2.1.x · Cited by 270 · cited 1×
“Furthermore, the amount and type of melanin produced and transferred to the keratinocytes with subsequent incorporation, aggregation and degradation influences skin complexion coloration [3].”
BackgroundSelf-citationTachibana, M., Takeda, K., Nobukuni, Y., Urabe, K., Long, J. E., Meyers, K. A., Aaronson, S. A., & Miki, T. (1996) · Nature Genetics · doi:10.1038/ng0996-50 · Cited by 257 · cited 2×
“melanocyte cellular differentiation as well as the transcription of melanogenic enzymes (tyrosinase, TYRP1 and TYRP2) and melanosome structural proteins (MART-1 and PMEL17) [13-15].”
BackgroundHalaban, R., Cheng, E., Zhang, Y., Moellmann, G., Hanlon, D., Michalak, M., Setaluri, V., & Hebert, D. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6210 · Cited by 257
García‐Borrón, J. C., & Solano, F. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.02012.x · Cited by 251 · cited 2×
“Specifically, the enzyme catalyzes the hydroxylation of the monophenol L-tyrosine to the o-diphenol 3,4-dihydroxyphenylalanine (DOPA) and the oxidation of DOPA to the o-quinone DOPAquinone (Scheme 1) [8,9].”
BackgroundThe Quest for the Mechanism of Melanin Transfer
Van Den Bossche, K., Naeyaert, J., & Lambert, J. (2006) · Traffic · doi:10.1111/j.1600-0854.2006.00425.x · Cited by 246
Fitton, A., & Goa, K. L. (1991) · Drugs · doi:10.2165/00003495-199141050-00007 · Cited by 243
Inhibitory effect of magnesium l-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo
Kameyama, K., Sakai, C., Kondoh, S., Yonemoto, K., Nishiyama, S., Tagawa, M., Murata, T., Ohnuma, T., Quigley, J., Dorsky, A., et al. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90830-0 · Cited by 242
Xu, W., Gong, L., Haddad, M. M., Bischof, O., Campisi, J., Yeh, E. T. H., & Medrano, E. E. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4803 · Cited by 241 · cited 1×
“ERK activation, in those cases, is thought to result in phosphorylation of MITF and its subsequent ubiquitination and degradation [25,28-30].”
BackgroundInhibition of Melanosome Transfer Results in Skin Lightening1
Seiberg, M., Paine, C., Sharlow, E., Eisinger, M., Shapiro, S. S., Andrade-Gordon, P., & Costanzo, M. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00035.x · Cited by 238 · cited 4×
“Therefore, modulation of PAR-2 activity augments or decreases melanosome transfer and in turn skin pigmentation [99,103-106].”
BackgroundInfluentialThe protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions
Seiberg, M., Paine, C., Sharlow, E., Andrade-Gordon, P., Costanzo, M., Eisinger, M., & Shapiro, S. S. (2000) · Experimental Cell Research · doi:10.1006/excr.1999.4692 · Cited by 238 · cited 3×
“Therefore, modulation of PAR-2 activity augments or decreases melanosome transfer and in turn skin pigmentation [99,103-106].”
BackgroundThe Treatment of Melasma 20% Azelaic Acid versus 4% Hydroquinone Cream
Baliña, L. M., & Graupe, K. (1991) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1991.tb04362.x · Cited by 227
Modulation of Melanogenesis by Aloesin: A Competitive Inhibitor of Tyrosinase
Jones, K., Hughes, J., Hong, M., Jia, Q., & Orndorff, S. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.02014.x · Cited by 209 · cited 2×
“The two adhere to different mechanisms of action where aloesin exhibits noncompetitive inhibition while arbutin inhibits competitively [49,64,69-71].”
BackgroundKim, D.-S., Hwang, E.-S., Lee, J.-E., Kim, S.-Y., Kwon, S.-B., & Park, K.-C. (2003) · Journal of Cell Science · doi:10.1242/jcs.00366 · Cited by 206 · cited 1×
“, which the authors hypothesize, may play an important role in the inhibition of melanogenesis [25-27].”
BackgroundNiacinamide: A B Vitamin that Improves Aging Facial Skin Appearance
Bissett, D. L., Oblong, J. E., & Berge, C. A. (2005) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2005.31732 · Cited by 202 · cited 1×
“Topical niacinamide is described to have several benefits on aging skin including but not limited to improved barrier function, improved appearance of photoaged facial skin (including texture, hyperpigmentation, redness, fine lines and wrinkles) and reduced sebum production [92,94-97].”
BackgroundNordlund, J., Grimes, P., & Ortonne, J. (2006) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2006.01670.x · Cited by 195 · cited 1×
“The compound can be found in wheat, tea, berries, beer and coffee, but is detoxified within the liver into inert compounds [6,47].”
BackgroundLinoleic acid and α-linolenic acid lightens ultraviolet-induced hyperpigmentation of the skin
Ando, H., Ryu, A., Hashimoto, A., Oka, M., & Ichihashi, M. (1998) · Archives of Dermatological Research · doi:10.1007/s004030050320 · Cited by 191 · cited 2×
“easily peroxidized, which in combination with an increase in epidermal turnover, correlate with an inhibitory effect on melanogenesis in vivo [51,115].”
BackgroundBissett, D. L., Miyamoto, K., Sun, P., Li, J., & Berge, C. A. (2004) · International Journal of Cosmetic Science · doi:10.1111/j.1467-2494.2004.00228.x · Cited by 190 · cited 2×
“Topical niacinamide is described to have several benefits on aging skin including but not limited to improved barrier function, improved appearance of photoaged facial skin (including texture, hyperpigmentation, redness, fine lines and wrinkles) and reduced sebum production [92,94-97].”
BackgroundTopical Vitamin C: A Useful Agent for Treating Photoaging and Other Dermatologic Conditions
Farris, P. K. (2005) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2005.31725 · Cited by 187 · cited 2×
“AsA acts as an ROS scavenger by donating electrons to neutralize free radicals found in the aqueous compartment of the cell [10,80].”
BackgroundEnglaro, W., Bertolotto, C., Buscà, R., Brunet, A., Pagès, G., Ortonne, J.-P., & Ballotti, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9966 · Cited by 185 · cited 1×
“have also demonstrated that TGF-β1 influences the extracellular-signal related kinase (ERK) pathway and down-regulates MITF as well as melanogenic enzyme production [20,22,24,25].”
BackgroundShibahara, S., Takeda, K., Yasumoto, K.-I., Udono, T., Watanabe, K.-I., Saito, H., & Takahashi, K. (2001) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.0022-202x.2001.00010.x · Cited by 184 · cited 2×
“melanocyte cellular differentiation as well as the transcription of melanogenic enzymes (tyrosinase, TYRP1 and TYRP2) and melanosome structural proteins (MART-1 and PMEL17) [13-15].”
BackgroundActivation of the Mitf promoter by lipid‐stimulated activation of p38‐stress signalling to CREB
Saha, B., Singh, S. K., Sarkar, C., Bera, R., Ratha, J., Tobin, D. J., & Bhadra, R. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00348.x · Cited by 178 · cited 1×
“ribosomal S6 kinase (RSK), glycogen synthase kinase-3b (GSK3b), p38 stress signaling and mitogen-activated protein kinase (MAPK) pathways by currently undefined mechanisms/pathways [15,18,20,21].”
BackgroundBuscà, R., Berra, E., Gaggioli, C., Khaled, M., Bille, K., Marchetti, B., Thyss, R., Fitsialos, G., Larribère, L., Bertolotto, C., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501067 · Cited by 178 · cited 1×
“Pertaining to survival, MITF regulates the anti-apoptotic molecule Bcl-2 as well as additional survival genes [33,34].”
BackgroundYamakoshi, J., Otsuka, F., Sano, A., Tokutake, S., Saito, M., Kikuchi, M., & Kubota, Y. (2003) · Pigment Cell Research · doi:10.1046/j.1600-0749.2003.00093.x · Cited by 172
Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes
Kim, D.-S., Kim, S.-Y., Chung, J.-H., Kim, K.-H., Eun, H.-C., & Park, K.-C. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00024-4 · Cited by 168 · cited 1×
“, which the authors hypothesize, may play an important role in the inhibition of melanogenesis [25-27].”
BackgroundThe Pigmentary System: Physiology and Pathophysiology
(2006) · Wiley eBooks · doi:10.1002/9780470987100 · Cited by 168
Fukuzawa, K., & Gebicki, J. M. (1983) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(83)90290-4 · Cited by 165
An Alternative Approach to Depigmentation by Soybean Extracts via Inhibition of the PAR-2 Pathway
Paine, C., Sharlow, E., Liebel, F., Eisinger, M., Shapiro, S., & Seiberg, M. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01291.x · Cited by 160
DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency
Boissy, R. E., Visscher, M., & DeLong, M. A. (2005) · Experimental Dermatology · doi:10.1111/j.0906-6705.2005.00337.x · Cited by 155 · cited 1×
“The reversibility of dA’s impact on skin pigmentation suggests that the compound does not permanently destroy melanocytes [20,54,55].”
BackgroundSelf-citationInhibition of PAX3 by TGF-β Modulates Melanocyte Viability
Yang, G., Li, Y., Nishimura, E. K., Xin, H., Zhou, A., Guo, Y., Dong, L., Denning, M. F., Nickoloff, B. J., & Cui, R. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.11.002 · Cited by 155
Kim, D.-S., Park, S.-H., & Park, K.-C. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.10.023 · Cited by 154 · cited 2×
“TGF-β1 is believed to mediate the down-regulation of the MITF promoter activity, reducing the production of tyrosinase, TYRP-1, TYRP-2 and MITF protein levels [20,22].”
BackgroundEffect of Arbutin on Melanogenic Proteins in Human Melanocytes
CHAKRABORTY, A. K., FUNASAKA, Y., KOMOTO, M., & ICHIHASHI, M. (1998) · Pigment Cell Research · doi:10.1111/j.1600-0749.1998.tb00731.x · Cited by 153 · cited 1×
“Higher concentrations of arbutin are more efficacious than lower concentrations, but may cause paradoxical hyperpigmentation [20,45,49,51,53].”
BackgroundThe protease-activated receptor-2 upregulates keratinocyte phagocytosis
Sharlow, E. R., Paine, C. S., Babiarz, L., Eisinger, M., Shapiro, S., & Seiberg, M. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.17.3093 · Cited by 150
Ando, H., Funasaka, Y., Oka, M., Ohashi, A., Furumura, M., Matsunaga, J., Matsunaga, N., Hearing, V. J., & Ichihashi, M. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33493-3 · Cited by 143
Hachiya, A., Kobayashi, A., Yoshida, Y., Kitahara, T., Takema, Y., & Imokawa, G. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63260-9 · Cited by 134 · cited 1×
“UV radiation can also produce reactive oxygen species (ROS) in the skin that may induce melanogenesis, DNA damage, melanocyte proliferation and/or apoptosis [76,77].”
BackgroundNewton, R. A., Cook, A. L., Roberts, D. W., Leonard, J. H., & Sturm, R. A. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700840 · Cited by 123 · cited 2×
“Additionally, further analysis of the resveratrol treated NHM displayed ER-retained immature tyrosinase, suggesting disrupted trafficking of tyrosinase in the GERL and elevated proteolytic degradation [75].”
BackgroundResultSkin‐lightening products revisited
Petit, L., & Piérard, G. E. (2003) · International Journal of Cosmetic Science · doi:10.1046/j.1467-2494.2003.00182.x · Cited by 118 · cited 3×
“Azelaic acid (1,7-heptanedicarboxyilic acid, AZA) is a naturally occurring non-toxic straight chain, saturated dicarboxylic acid derived from Pityrosporum ovale [57,63,64].”
BackgroundMolecular Design of Antibrowning Agents
Kubo, I., Kinst-Hori, I., Kubo, Y., Yamagiwa, Y., Kamikawa, T., & Haraguchi, H. (2000) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf990926u · Cited by 116
Greatens, A., Hakozaki, T., Koshoffer, A., Epstein, H., Schwemberger, S., Babcock, G., Bissett, D., Takiwaki, H., Arase, S., Wickett, R. R., et al. (2005) · Experimental Dermatology · doi:10.1111/j.0906-6705.2005.00309.x · Cited by 115 · cited 3×
“This inhibition is reversible and is shown to be enhanced by the presence of niacinamide [93].”
BackgroundSelf-citationModifying skin pigmentation – approaches through intrinsic biochemistry and exogenous agents
Brenner, M., & Hearing, V. J. (2008) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2008.02.001 · Cited by 113 · cited 1×
“Specifically, plasma membrane lectins and their glycoconjugates are thought to interrupt melanocyte and keratinocyte contact and interaction, by binding their specific plasma membrane receptors, inhibiting melanosome transfer [109].”
BackgroundGlutathione as a depigmenting agent: an overview
Villarama, C. D., & Maibach, H. I. (2005) · International Journal of Cosmetic Science · doi:10.1111/j.1467-2494.2005.00235.x · Cited by 112 · cited 1×
“Yet, other mechanisms of action proposed for glutathione include (A) the direct inactivation of tyrosinase by chelating copper within the enzyme’s active site, (B) mediating the transition from eumelanogenesis to pheomelanogenesis, as glutathione participates in the conversion of dopaquinone to pheomelanin, (C) antiox…”
BackgroundScott, G., Rodriguez-Burford, C., Seiberg, M., Han, R., Babiarz, L., Grizzle, W., Bell, W., Pentland, A., & Deng, A. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01575.x · Cited by 110 · cited 1×
“darker skin individuals [98,104,107].”
Lin, C. B., Babiarz, L., Liebel, F. T., Kizoulis, M. G., Gendimenico, G. J., Seiberg, M., Price, E. R., & Fisher, D. E. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.19615.x · Cited by 108 · cited 2×
“ribosomal S6 kinase (RSK), glycogen synthase kinase-3b (GSK3b), p38 stress signaling and mitogen-activated protein kinase (MAPK) pathways by currently undefined mechanisms/pathways [15,18,20,21].”
BackgroundA Melanocyte–Keratinocyte Coculture Model to Assess Regulators of Pigmentation in Vitro
Lei, T., Virador, V. M., Vieira, W. D., & Hearing, V. J. (2002) · Analytical Biochemistry · doi:10.1006/abio.2002.5665 · Cited by 107
Jin, Y. H., Lee, S. J., Chung, M. H., Park, J. H., Park, Y. I., Cho, T. H., & Lee, S. K. (1999) · Archives of Pharmacal Research · doi:10.1007/bf02976355 · Cited by 102 · cited 1×
“The two adhere to different mechanisms of action where aloesin exhibits noncompetitive inhibition while arbutin inhibits competitively [49,64,69-71].”
BackgroundChemical derivatization for the analysis of drugs by GC-MS - A conceptual review
Lin, D., Wang, S., Wu, C., Chen, B.-G., & Liu, R. H. (2020) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.2373 · Cited by 100
Choi, C. M., & Berson, D. S. (2006) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2006.06.010 · Cited by 99
New and Experimental Treatments of Cloasma and Other Hypermelanoses
Picardo, M., & Carrera, M. (2007) · Dermatologic Clinics · doi:10.1016/j.det.2007.04.012 · Cited by 98 · cited 10×
“2000/6/EC) and formulations have been withdrawn from cosmetics and are available only through prescription [10,20,50].”
BackgroundInfluentialJimbow, K. (1991) · Archives of Dermatology · doi:10.1001/archderm.1991.01680090092011 · Cited by 92
Sphingosylphosphorylcholine‐induced ERK activation inhibits melanin synthesis in human melanocytes
Kim, D., Park, S.-H., Kwon, S., Park, E., Huh, C., Youn, S. W., & Park, K. (2005) · Pigment Cell Research · doi:10.1111/j.1600-0749.2005.00287.x · Cited by 88 · cited 3×
“ERK activation, in those cases, is thought to result in phosphorylation of MITF and its subsequent ubiquitination and degradation [25,28-30].”
BackgroundHydrogen Peroxide as an Inducer of Elevated Tyrosinase Level in Melanoma Cells
Karg, E., Odh, G., Wittbjer, A., Rosengren, E., & Rorsman, H. (1993) · Journal of Investigative Dermatology · doi:10.1038/jid.1993.78 · Cited by 87
YAMAMOTO, Y., UEDE, K., YONEI, N., KISHIOKA, A., OHTANI, T., & FURUKAWA, F. (2006) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2006.00003.x · Cited by 87
Melanosome formation in the goldfish: the role of multivesicular bodies
Turner, W. A., Taylor, J. D., & Tchen, T. T. (1975) · Journal of Ultrastructure Research · doi:10.1016/s0022-5320(75)80004-9 · Cited by 86 · cited 1×
“Melanin synthesis ensues subsequent to the sorting and trafficking of these proteins to the melanosome [1,2].”
BackgroundDerian, C. K., Eckardt, A. J., & Andrade‐Gordon, P. (1997) · PubMed · Cited by 84
Effective Over-the-Counter Acne Treatments
Bowe, W. P., & Shalita, A. R. (2008) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2008.07.004 · Cited by 83 · cited 3×
“The accelerated desquamation of the stratum corneum by AHAs is complemented by a direct inhibition of tyrosinase, without influencing mRNA or protein expression [51,110,111].”
BackgroundShimizu, K., Kondo, R., Sakai, K., Takeda, N., Nagahata, T., & Oniki, T. (2001) · Lipids · doi:10.1007/s11745-001-0847-9 · Cited by 82 · cited 1×
“The depigmenting effect of α-Toc can further be attributed to an increase in intracellular glutathione and the inhibition of tyrosinase [51,83-85].”
BackgroundMishima, Y., & Imokawa, G. (1983) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12542192 · Cited by 79
Minwalla, L., Zhao, Y., Cornelius, J., Babcock, G. F., Wickett, R. R., Le Poole, I. C., & Boissy, R. E. (2001) · Pigment Cell Research · doi:10.1034/j.1600-0749.2001.140308.x · Cited by 77 · cited 4×
“Cellular recognition between melanocytes and keratinocytes is an important event involved in melanosome transfer [87].”
BackgroundInfluentialSelf-citationThe expression and activation of protease-activated receptor-2 correlate with skin color
Babiarz‐Magee, L., Chen, N., Seiberg, M., & Lin, C. B. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00133.x · Cited by 76
(1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1833 · Cited by 69
Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives
Chawla, S., deLong, M. A., Visscher, M. O., Wickett, R. R., Manga, P., & Boissy, R. E. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08864.x · Cited by 68 · cited 2×
“The reversibility of dA’s impact on skin pigmentation suggests that the compound does not permanently destroy melanocytes [20,54,55].”
BackgroundSelf-citationInsight into skin lightening cosmeceuticals for women of color.
Badreshia, S., & Draelos, Z. D. (2007) · PubMed · Cited by 68
Virador, V., Matsunaga, N., Matsunaga, J., Valencia, J., Oldham, R. J., Kameyama, K., Peck, G. L., Ferrans, V. J., Vieira, W. D., Abdel‐Malek, Z. A., et al. (2001) · Pigment Cell Research · doi:10.1034/j.1600-0749.2001.140410.x · Cited by 66
Imokawa, G. (1989) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12277369 · Cited by 62 · cited 2×
“Higher concentrations of arbutin are more efficacious than lower concentrations, but may cause paradoxical hyperpigmentation [20,45,49,51,53].”
BackgroundNatural products with skin - Whitening effects
Lin, J.-W., Chiang, H., Lin, Y.-C., & Wen, K.-C. (2020) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.2366 · Cited by 62
The depigmenting effect of ?-tocopheryl ferulate on human melanoma cells
Funasaka, Chakraborty, Komoto, Ohashi, & Ichihashi (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02916.x · Cited by 54 · cited 1×
“A study completed investigating the biochemical effect of α-TF in human melanoma cells suggests the whitening effect is due to tyrosinase inhibition at the post-transcriptional level, possibly by an unidentified secondary molecule [50,86].”
BackgroundUltrasound enhanced skin‐lightening effect of vitamin C and niacinamide
Hakozaki, T., Takiwaki, H., Miyamoto, K., Sato, Y., & Arase, S. (2006) · Skin Research and Technology · doi:10.1111/j.0909-752x.2006.00186.x · Cited by 52
Imokawa, G., & Mishima, Y. (1984) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12263562 · Cited by 52 · cited 1×
“Treatment with various agents that inhibit N-glycosylation can result in the down-regulation of melanosomal enzyme activity and reduced melanosomal maturation [9,10,37,38].”
BackgroundComparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent.
Hamed, S., Sriwiriyanont, P., deLong, M. A., Visscher, M. O., Wickett, R. R., & Boissy, R. E. (2006) · PubMed · Cited by 51
Self-citationTopical niacinamide and barrier enhancement.
Bissett, D. L. (2002) · PubMed · Cited by 50
Negroiu, G., Branza‐Nichita, N., Petrescu, A., Dwek, R. A., & Petrescu, S. M. (1999) · Biochemical Journal · doi:10.1042/bj3440659 · Cited by 48 · cited 1×
“This glycosylation is critical for the proper maturation of tyrosinase [10,36,37].”
BackgroundN-Glycosylation Processing and Glycoprotein Folding−Lessons from the Tyrosinase-Related Proteins
Branza‐Nichita, N., Petrescu, A., Negroiu, G., Dwek, R. A., & Petrescu, S. M. (2000) · Chemical Reviews · doi:10.1021/cr990291y · Cited by 48
Natural Products with Skin-Whitening Effects
林振文, 江秀梅, 林羿君, & 溫國慶 (2008) · Journal of Food and Drug Analysis · Cited by 48
Nair, X., Parab, P. V., Suhr, L., & Tramposch, K. M. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12363627 · Cited by 41 · cited 1×
“The mechanism of action likely involves the inhibition of tyrosinase, the dispersion of keratinocyte pigmented granules, reduction in pigment transfer and a reduction in corneocyte cohesion with an associated acceleration of epidermal turnover [20,51,116].”
BackgroundIdentification of Quinolines that Inhibit Melanogenesis by Altering Tyrosinase Family Trafficking
Ni‐Komatsu, L., Tong, C., Chen, G., Brindzei, N., & Orlow, S. J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050633 · Cited by 41 · cited 1×
“Yet these quinolines, such as chloroquine, were not reported to influence the enzymatic activity of tyrosinase, but rather the intracellular trafficking of tyrosinase related proteins and lysosome associated membrane protein-1 (LAMP-1) [52].”
BackgroundA secreted serine protease can induce apoptosis in Pam212 keratinocytes.
Marthinuss, J., Andrade‐Gordon, P., & Seiberg, M. (1995) · PubMed · Cited by 37
Kim, D. H., Hwang, J., Baek, H. S., Kim, K., Lee, B. G., Chang, I., Kang, H., & Lee, O. S. (2003) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.51.113 · Cited by 37 · cited 1×
“, 5-[(3-aminopropyl)phosphinooxy]-2-(hydroxymethyl)-4Hpyran-4-one (Kojyl-APPA), showed increased skin penetration and pigment lightening efficacy in melanoma and normal human melanocytes [20,62].”
BackgroundCentaureidin promotes dendrite retraction of melanocytes by activating Rho
Ito, Y., Kanamaru, A., & Tada, A. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.01.003 · Cited by 35 · cited 3×
“Centaureidin is believed to directly or indirectly activate Rho, leading to melanocyte dendrite retraction without influencing melanogenic enzyme expression or melanin synthesis [88,91].”
BackgroundKeeling, J., Cardona, L., Benitez, A., Epstein, R., & Rendon, M. I. (2008) · PubMed · Cited by 34
Maresca, V., Flori, E., Cardinali, G., Briganti, S., Lombardi, D., Mileo, A. M., Paggi, M. G., & Picardo, M. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20543 · Cited by 34 · cited 1×
“Other factors explored for their ability to modulate tyrosinase glycosylation include calcium D-pantetheine-S-sulfonate [43], ferritin [44] and glutathione [45].”
BackgroundMitf dosage as a primary determinant of melanocyte survival after ultraviolet irradiation
Hornyak, T. J., Jiang, S., Guzmán, E. A., Scissors, B. N., Tuchinda, C., He, H., Neville, J. D., & Strickland, F. M. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00551.x · Cited by 34 · cited 1×
“It has recently been demonstrated that melanocytes deficient in MITF expression are compromised in their resistance to UV-induced apoptosis [35].”
BackgroundChoi, H., Ahn, S., Chang, H., Cho, N. S., Joo, K., Lee, B. G., Chang, I., & Hwang, J. S. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00515.x · Cited by 32 · cited 1×
“, treatment of HM3KO melanoma cells with deoxynojirimycin, a α-glucosidase inhibitor that disrupts early ER N-glycan processing, and deoxymannojirimycin, an inhibitor of α-1,2-mannosidase which are thought to be responsible for late glycan processing, showed inhibition of glycosylation, transportation of tyrosinase to…”
BackgroundTopical niacinamide provides skin aging appearance benefits while enhancing barrier function
Bissett, D. (2003) · Medical Entomology and Zoology · Cited by 32
Boissy, R. E., Huizing, M., & Gahl, W. A. (2006) · The Pigmentary System · doi:10.1002/9780470987100.ch7 · Cited by 28
Self-citationEffects of lysophosphatidic acid on melanogenesis
Kim, D.-S., Park, S.-H., Kwon, S.-B., Youn, S. W., & Park, K. (2003) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.11.002 · Cited by 28 · cited 1×
“In a distinct study, the authors demonstrated that lysophosphatidic acid (LPA), a serum phospholipid released by activated platelets, mediates the reduction of MITF promoter activity as well as MITF and tyrosinase protein and melanin synthesis in Mel-Ab cells, an immortalized mouse melanocyte line [31].”
BackgroundEnhancement of tyrosinase inhibition of the extract of Veratrum patulum using cellulase
Kim, D. H., Kim, J. H., Baek, S. H., Seo, J. H., Kho, Y. H., Oh, T. K., & Lee, C. H. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20189 · Cited by 24 · cited 2×
“There are more than 30 stilbene and stilbene glycosides with a structural skeleton comprised of two aromatic rings linked by an ethylene bridge [20,72].”
BackgroundDepigmenting Effects of Calcium d ‐Pantetheine‐S‐Sulfonate on Human Melanocytes
FRANCHI, J., COUTADEUR, M. C., Marteau, C., Mersel, M., & Kupferberg, A. (2000) · Pigment Cell Research · doi:10.1034/j.1600-0749.2000.130308.x · Cited by 24 · cited 1×
“Other factors explored for their ability to modulate tyrosinase glycosylation include calcium D-pantetheine-S-sulfonate [43], ferritin [44] and glutathione [45].”
BackgroundLin, C. B., Chen, N., Scarpa, R., Guan, F., Babiarz‐Magee, L., Liebel, F., Li, W., Kizoulis, M., Shapiro, S., & Seiberg, M. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00441.x · Cited by 23 · cited 2×
“The peptide of mouse PAR-2 cleavage sequence SLIGRL is an equipotent activator of mouse and human PAR-2 receptor in comparison to the human tethered ligand SLIGKV [100].”
BackgroundEffects of methylophiopogonanone B on melanosome transfer and dendrite retraction
Ito, Y., Kanamaru, A., & Tada, A. (2006) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2005.12.015 · Cited by 21 · cited 3×
“has shown that treatment of melanocyte and keratinocyte cocultures with methylophiopogonanone B (5,7-dihydroxy-6,8-dimethyl-3-(4-methoxybenzyl)chroman4-one, MOPB), an agent reported to activate Rho and induce microtubule disorganization and tubule depolymerization, appeared to reduce melanosome transfer [89,90].”
BackgroundToxicological Aspects of Melanin and Melanogenesis
Land, E. J., Ramsden, C. A., & Riley, P. A. (2006) · Wiley eBooks · doi:10.1002/9780470987100.ch18 · Cited by 18 · cited 1×
“As other active derivatives of the compound cause an increase in protein glycosylation in B16 melanoma cells, the authors hypothesize that the test compound inhibited tyrosinase by modifying the sugar moieties of the enzyme [40,41].”
BackgroundTerao, M., Tomita, K., OKI, T., Tabe, L. M., Gianni’, M., & Garattini, E. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90276-o · Cited by 17 · cited 1×
“As other active derivatives of the compound cause an increase in protein glycosylation in B16 melanoma cells, the authors hypothesize that the test compound inhibited tyrosinase by modifying the sugar moieties of the enzyme [40,41].”
BackgroundA promising new treatment for solar lentigines.
Colby, S., Schwartzel, E. H., Huber, F., Highton, A., Altman, D. J., Epinette, W. W., & Lyon, E. (2003) · PubMed · Cited by 15
Topical Treatment of Pigmentary Disorders
Halder, R. M., & Nordlund, J. J. (2006) · doi:10.1002/9780470987100.ch59 · Cited by 12 · cited 8×
“fungal metabolite obtained from species of Acetobacter, Aspergillus and Penicillium [48,49].”
BackgroundInfluentialBerson, D. S. (2008) · PubMed · Cited by 9
Melasma: current and future treatments
Berardesca, E., Ardigò, M., Berardesca, M., & Cameli, N. (2008) · Expert Review of Dermatology · doi:10.1586/17469872.3.2.187 · Cited by 7 · cited 1×
“Tretinoin (all-trans retinoic acid) is a derivative of vitamin A that is thought to have an inhibitory effect on tyrosinase transcription [117].”
BackgroundA novel agent, methylophiopogonanone B, promotes Rho activation and tubulin depolymerization
Ito, Y., Kanamaru, A., & Tada, A. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9336-y · Cited by 6 · cited 2×
“has shown that treatment of melanocyte and keratinocyte cocultures with methylophiopogonanone B (5,7-dihydroxy-6,8-dimethyl-3-(4-methoxybenzyl)chroman4-one, MOPB), an agent reported to activate Rho and induce microtubule disorganization and tubule depolymerization, appeared to reduce melanosome transfer [89,90].”
BackgroundFerguson, J., Rogers, P., Kèlland, L. R., & Robins, D. J. (2005) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504005775082048 · Cited by 5 · cited 1×
“suggests that NCAP may undergo oxidation by tyrosinase to form a reactive o-quinone that is capable of alkylating thiol groups of essential enzymes, which may interfere with cell growth and proliferation [61].”
BackgroundTranscriptional Regulation of Melanocyte Function
Takeda, K., & Shibahara, S. (2006) · Wiley eBooks · doi:10.1002/9780470987100.ch13 · Cited by 4 · cited 1×
“syndrome type IIA [16,17].”
Zhu, W., & Zhang, R. (2005) · CRC Press eBooks · doi:10.3109/9781420020854-17 · Cited by 4
Research works printed but not linked: 1
- Urabe K Nakayama J Hori Y Mixed epidermal and dermal hypermelanoses The Pigmentary System: Physiology and Pathophysiology Nordlund JJ Boissy RE Hearing VJ King RA Oetting WS Ortonne JP Oxford University Press New York, NY, USA 1998 909 913
Cited by
Liquorice ( Glycyrrhiza glabra ): A phytochemical and pharmacological review
Pastorino, G., Cornara, L., Soares, S., Rodrigues, F., & Oliveira, M. B. P. P. (2018) · Phytotherapy Research · doi:10.1002/ptr.6178 · Cited by 804
“In particular, glabridin, glabrene, isoliquiritigenin, licochalcone A, and liquiritin have been reported as G. glabra compounds able to inhibit the tyrosinase activity (Ebanks, Wickett, & Boissy, 2009; Nerya et al., 2003) .”
BackgroundThe Roles of Vitamin C in Skin Health.
Pullar, J., Carr, A., & Vissers, M. (2017) · Nutrients · doi:10.3390/nu9080866 · Cited by 756
“The inhibition in melanin production by vitamin C is thought to be due to the vitamin’s ability to reduce the ortho-quinones generated by tyrosinase [94], although other mechanisms are also possible [96].”
BackgroundMechanisms regulating melanogenesis*
Videira, I. F. D. S., Moura, D. F. L., & Magina, S. (2013) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962013000100009 · Cited by 677
Kojic acid applications in cosmetic and pharmaceutical preparations
Saeedi, M., Eslamifar, M., & Khezri, K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.006 · Cited by 419
Thiboutot, D. M., Dréno, B., Abanmi, A., Alexis, A. F., Araviiskaia, E., Barona Cabal, M. I., Bettoli, V., Casintahan, F., Chow, S., da Costa, A., et al. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.09.078 · Cited by 418
“Table III reviews pathways that are targets of medical intervention in pigmentation disorders.(98,99) Chemical peels, lasers, and other light therapies may also be used for PIH; however, these methods can also cause pigmentation problems so should be used with care.”
Background
Metadata
- Authors
- Ebanks, J. P., Wickett, R. R., & Boissy, R. E.
- Affiliations
- University of Cincinnati (US)
- Corresponding author
- Boissy, Raymond E.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2009-09-15
- Volume
- 10
- Issue
- 9
- Pages
- 4066-4087
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC2769151
- OpenAlex
- W2111479139
- Cited by
- 323
- References
- 127
- Citations by year
- 2026: 18 · 2025: 24 · 2024: 32 · 2023: 23 · 2022: 22 · 2021: 28 · 2020: 18 · 2019: 28 · 2018: 36 · 2017: 30 · 2016: 9 · 2015: 14 · 2014: 10 · 2013: 7 · 2012: 11
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
- Keywords
- skin pigmentation, melanogenesis, tyrosinase inhibition, melanocyte homeostasis, melanosome transfer, keratinocytes, depigmenting agents
- MeSH terms
- Animals, Enzyme Inhibitors, Humans, Melanocytes, Protein Processing, Post-Translational, Skin Pigmentation, Monophenol Monooxygenase, Signal Transduction, Gene Expression Regulation, Enzymologic, Melanosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.